Close Menu

NEW YORK (GenomeWeb) – Molecular diagnostics firm Lineagen today announced the close of the second and final tranche of its Series C financing round that brought in a total of $15.8 million. 

The second tranche raised about $12.2 million and follows a $3.5 million first tranche that the Salt Lake City-based firm raised in December 2013. Lineagen said that it also received a $4 million secured debt facility with Silicon Valley Bank as part of the initial tranche.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports that a Russian Academy of Sciences commission has led to the retraction of hundreds of scientific papers.

The Los Angeles Times' Daily Pilot reports the chief executive of Vantari Genetics has pleaded guilty in a kickback scheme.

News 4 Jax reports that a Florida bill to prevent life and long-term care insurers from using genetic information in their coverage decisions has easily passed one committee.

In Science this week: potentially pathogenic mutations found in hematopoietic stem cells from young healthy donors, and more.